New Drug Combo Helps Hard-to-Treat Hepatitis C
NIH study focused largely on black patients, who haven’t fared as well with current treatmentsContinue Reading
NIH study focused largely on black patients, who haven’t fared as well with current treatmentsContinue Reading
People with type 2 diabetes plus a certain variant of DNA had 36 percent higher risk, study foundContinue Reading
Rate at which retailers violate under-18 sales ban has fallen to just 9 percentContinue Reading
Program tackling over-prescription to dementia patients is working, government data suggestContinue Reading
Lower hospitalization rates for rotavirus infection seen in all age groups, researchers reportContinue Reading
U.S. health officials still haven’t identified source of more than 600 infectionsContinue Reading
NIH study focused largely on black patients, who haven’t fared as well with current treatmentsContinue Reading
People with type 2 diabetes plus a certain variant of DNA had 36 percent higher risk, study foundContinue Reading
Relatively low level of inflammation may hold the key, researchers sayContinue Reading
Mirvaso works by constricting dilated blood vessels of the face, company saysContinue Reading
© 2021 WeeklyMD.com - All Rights Reserved.